Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bayesian N-of-1 trials of mexiletine in non-dystrophic myotonia
2010-024026-38Phase 2Active
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mexiletine in non-dystrophic myotonia (NDM), sponsored by Radboud University Medical Center. Primary endpoint: Individual N-of-1 primary endpoints per treatment pair. Started Feb 2011; status: active.
02
Drugs
mexiletine
03
Conditions
non-dystrophic myotonia (NDM)
Beyond the preview
Go deeper on 2010-024026-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024026-38.